Provenienza dei contatti di primo grado di Luiza Jedlina
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.
14
| Public Company | Pharmaceuticals: Major | 14 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Luiza Jedlina tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Imperial College London | College/University | Doctorate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
| Université de Bordeaux | College/University | Graduate Degree | |
| University of Lund | College/University | Director/Board Member Doctorate Degree Graduate Degree Undergraduate Degree | |
| Umea Universitet | College/University | Graduate Degree | |
Novation Pharmaceuticals, Inc.
 Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Medical/Nursing Services | Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| Combio A/S | Chief Executive Officer | ||
Merck Sharp & Dohme (Sweden) AB
 Merck Sharp & Dohme (Sweden) AB Medical DistributorsDistribution Services Part of Merck & Co., Inc., Merck Sharp & Dohme (Sweden) AB is a biopharmaceutical company based in Stockholm, Sweden. MSD Sweden is focused on inventing medicines and vaccines to save and improve lives, sharing a vision and mission to achieve this goal. The Swedish company was founded in 1974. The CEO is Björn Fredrik Niklas Andreasson. | Medical Distributors | Chief Tech/Sci/R&D Officer | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer Chairman | |
IQVIA Clinical AB
 IQVIA Clinical AB Pharmaceuticals: MajorHealth Technology IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
H. Lundbeck AB
 H. Lundbeck AB Pharmaceuticals: MajorHealth Technology H. Lundbeck AB operates as a pharmaceutical company specializing in psychiatric and neurological disorders. It offers a broad range of products within brain diseases such as depression, schizophrenia, Alzheimer, and Parkinson. The company is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| OxyPharma AB | Chief Executive Officer | ||
| Swedish Pharmaceutical Society | Director/Board Member | ||
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Founder Chairman | |
| Ideonfonden AB | Director/Board Member Chief Executive Officer | ||
| Accequa AB | Chairman Chief Executive Officer Founder | ||
| EMOTRA AB (PUBL) | Medical Specialties | Director/Board Member | |
| ARCEDE PHARMA AB | Miscellaneous Commercial Services | Director/Board Member | |
| University of Detroit Mercy School of Law | College/University | Graduate Degree | |
| GABATHER AB | Pharmaceuticals: Major | Founder Director/Board Member Founder Director of Finance/CFO Director/Board Member | |
| Portendo Standoff Detection AB | Founder | ||
Otsuka Pharma Scandinavia AB
 Otsuka Pharma Scandinavia AB Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharma Scandinavia AB is a pharmaceutical and nutraceutical company based in Stockholm, SE. Otsuka Pharma Scandinavia aims to improve the health of patients by focusing on some of the world's unresolved health issues and creating solutions and opportunities for some of the most challenging conditions of the body and mind. Otsuka Pharma Scandinavia is dedicated to making a difference for patients in their daily lives and focuses on getting the job done together as a team, guided by its values of integrity, compassion, excellence, creativity, and collaboration. The Swedish company is committed to conducting business ethically and in compliance with the laws and regulations of the countries where it operates. The company invests substantially in research and development in both common and rare conditions, with a network of 44 research institutes around the world. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INVENT MEDIC SWEDEN AB | Medical Specialties | Director of Finance/CFO | |
| Ceratmo AB | Director/Board Member | ||
| Biomedical Development Europe | Corporate Officer/Principal | ||
| CYXONE AB | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer Director/Board Member Chief Executive Officer | |
| Ub-Consulting AB | Chief Executive Officer | ||
| BICO GROUP AB | Biotechnology | Director/Board Member | |
| Celus Pharmaceuticals Ltd. | Chief Executive Officer | ||
Ledningsresurs Syd AB
 Ledningsresurs Syd AB Miscellaneous Commercial ServicesCommercial Services Ledningsresurs Syd AB provides corporate consulting services. Ola Skanung has been the CEO of the Swedish company since 2010. | Miscellaneous Commercial Services | Chief Executive Officer | |
| XO Sweden Wines & Spirits AB | Director/Board Member | ||
| Galecto Biotech AB | Founder Founder | ||
| Accequa GmbH | Director/Board Member Director/Board Member | ||
| Medcom-Advice AB | Director/Board Member | ||
| Aptahem Finans AB | Founder | ||
| Serstech Förvaltning AB | Founder | ||
| Mikeoo Holding AB | Founder | ||
| Holy Plantmedix AB | Founder | ||
| SENSIDOSE AB | Electronic Equipment/Instruments | Director/Board Member | |
| ALZINOVA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
| Svezia | 39 |
| Danimarca | 4 |
| Canada | 3 |
| Stati Uniti | 3 |
| Germania | 2 |
Settori
| Health Technology | 18 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Finance | 2 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 77 |
| Founder | 21 |
| Chairman | 19 |
| Chief Executive Officer | 18 |
| Corporate Officer/Principal | 17 |
Contatti più connessi
| Insiders | |
|---|---|
| Theresa Comiskey Olsen | 27 |
| Bert Roland Kari Junno | 17 |
| Ulla Cristina Glad | 15 |
| Kjell Göran Stenberg | 14 |
| Ulf Björklund | 14 |
| Knut Mikael Ingolf Lindstam | 13 |
| Jan Nilsson | 12 |
| Ingela Hallberg | 9 |
| Ola Skanung | 7 |
| Åsa Kornfeld | 7 |
| Anders Bylock | 6 |
| Johan Lindh | 3 |
| Maria Ekblad | 3 |
| Suzanne Kilany | 2 |
- Borsa valori
- Insiders
- Luiza Jedlina
- Connessioni Società
